MedTrace Logo

Informational Tool for Smoking Cessation in COPD Patients

NCT06872450 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-08-08

No results posted yet for this study

Summary

Chronic obstructive pulmonary disease (COPD) is a lung disease that affects nearly 8% of the adult population and causes 18,000 deaths per year in France. The most frequent cause of this pathology is smoking. COPD patients who stop smoking have a better quality of life, a marked a significant slowdown in disease progression and an increased life expectancy. Investigators propose to carry out a quantitative study among patients smokers suffering from COPD, by setting up a tool in the form of an motivational intervention specific to this population.

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

OTHER

informational intervention

informational intervention

Sponsors & Collaborators

  • Hopital Nord Franche-Comte

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-14
Primary Completion
2025-05-09
Completion
2025-05-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06872450 on ClinicalTrials.gov